Clinical Trials Directory

Trials / Completed

CompletedNCT01232205

Antioxidant Supplementation in Pregnant Women

Antioxidant Supplementation in Pregnant Women With Low Antioxidant Status

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
168 (actual)
Sponsor
Showa University · Academic / Other
Sex
Female
Age
20 Years – 40 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate the benefit of several micro nutrients of antioxidants (using milk) in a cohort of women with low antioxidant status and the changes in cell-free mRNA.

Detailed description

Preeclampsia remains one of leading causes of maternal and perinatal mortality and morbidity. Despite intensive research, the cause of preeclampsia has not been established. One of the theories is exaggeration of systemic inflammatory that might induce reactive oxygen species (ROS). It has been proposed that pregnancy will progress uneventfully if adequate antioxidant exists to buffer ROS. The ROS can induce endothelial dysfunction which leads to clinical symptoms of hypertension and proteinuria in preeclampsia. Several large randomized clinical trials of antioxidant supplementation have concluded that there were no benefits of antioxidants supplementation for prevention of preeclampsia. However, there is limited information about benefits of antioxidants in women with low antioxidant status at early gestation that deprived of the antioxidant most. Our aim, therefore, in this study was to assess whether early supplementation with milk enriched with vitamin and mineral, such as Cu, Zn, Mn, Fe, carotene, vitamin B6, B12, C, E, selenium, and calcium lowers the risk of preeclampsia in women with low antioxidant status at early gestation.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTmicronutrient antioxidantSupplementation with milk enriched with vitamin and mineral, such as Cu, Zn, Mn, Fe, carotene, vitamin B6, B12, C, E, selenium, and calcium
DIETARY_SUPPLEMENTControlsupplementation with milk

Timeline

Start date
2001-06-01
Primary completion
2009-12-01
Completion
2010-03-01
First posted
2010-11-02
Last updated
2010-12-02
Results posted
2010-12-02

Locations

1 site across 1 country: Indonesia

Source: ClinicalTrials.gov record NCT01232205. Inclusion in this directory is not an endorsement.